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More than 50 years ago, Leonard Hayflick and Paul Moorhead 
observed that fibroblasts from healthy human donors had a finite 
proliferation capacity in cell culture. When these cells reached 
their “Hayflick limit” they became irreversibly arrested, or “repli-
catively senescent” (Hayflick and Moorhead, 1961). A similar 
irreversible cell cycle arrest, now designated as “cellular senes-
cence,” can be induced by a variety of stresses, including (but not 
limited to) activation of oncogenes, telomere maintenance defects, 
oxidative stress, and excessive DNA damage (Campisi and d’Adda 
di Fagagna, 2007; Collado et al., 2007; Kuilman et al., 2010).
Senescent cells are believed to be very stable over long 
periods of time, both in culture as well as in tissues (although 
evidence for the latter is very limited). In this issue, Ivanov et al. are 
challenging this dogma by providing evidence that senescence 
may be a more dynamic process than we have previously appre-
ciated. They show that some senescent cells contain cytoplasmic 
chromatin fragments (CCFs) that apparently bud off from the 
nuclei. CCFs were found to be devoid of lamin A/C, but were 
highly positive for the histone variant -H2AX (a mark of DNA 
double-strand breaks) and enriched for the histone H3 lysine 27 
trimethyl modification (H3K27me3; a mark of heterochromatin). 
They also observed down-regulation of lamin B1 and a striking 
loss of nuclear envelope integrity; features that they speculate 
may permit CCF formation and release. Once in the cytoplasm, 
CCFs were engaged by the autophagy pathway and ultimately 
proteolytically degraded in lysosomes. A decrease in the nu-
clear content of core histones was also noted, the obvious impli-
cation being that this is causally connected with the generation 
and destruction of CCFs. Taken together, these results repre-
sent a challenge to the classical view of cellular senescence 
as a single end point, and point to a more fluid situation where 
Cellular senescence is a state of irreversible cell cycle 
arrest that has been documented to both suppress cancer 
and promote aging. Although not well understood, exten­
sive nuclear changes, including the remodeling of chro­
matin, take place as cells become senescent. In this issue, 
Ivanov et al. (2013. J. Cell Biol. http://dx.doi.org/
jcb.201212110) report that chromatin fragments are re­
leased from the nuclei of senescent cells and are sub­
sequently targeted for processing through the autophagy/ 
lysosomal pathway.
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important changes take place after the initial cell cycle arrest, 
and in all likelihood progress and evolve over extended periods 
of time (Fig. 1).
The concepts of “deepening” and “late” senescence have 
been suggested by a number of previous studies. -H2AX– 
positive DNA damage foci become very abundant as cells ap-
proach and enter senescence, but greatly diminish as the cultures 
are maintained for extended periods of time (Chen and Ozanne, 
2006). Passos et al. (2010) proposed that a persistent DNA dam-
age response triggers continued production of reactive oxygen 
species, forming a dynamic feedback loop that actively main-
tains a deep senescent state. De Cecco et al. (2013) reported that 
after cells become fully senescent by all conventional criteria, 
the expression of the long interspersed nuclear element (LINE) 
retrotransposon L1 increased dramatically during extended cul-
ture, culminating in active transposition. This is consistent with 
previous observations that Alu retrotransposon expression also 
increases in senescent cells (Wang et al., 2011). Retrotransposon 
transcripts are assembled in the cytoplasm with reverse tran-
scriptase and integrase (along other essential proteins) into ribo-
nucleoprotein particles that subsequently have to enter the 
nucleus in order to insert into new genomic locations. The loss 
of nuclear integrity observed by Ivanov et al. (2013) could 
be one explanation why deeply senescent cells are supportive 
of retrotransposition.
Depletion of core histones, without concomitant loss of 
DNA, has been noted to accompany aging in yeast and nematodes 
(Feser et al., 2010; Ni et al., 2012), and a reduction in the biosyn-
thesis of histones was reported in human fibroblasts during entry 
into senescence (O’Sullivan et al., 2010). Ivanov et al. (2013) ob-
served that steady-state levels of all core histones progressively 
decreased as cells were maintained in a senescent state. As a con-
sequence, one would anticipate a decompression of chromatin and 
a more “open” epigenome. This view is consistent with emerging 
literature from multiple species and model systems, suggesting 
that proper maintenance of heterochromatin has anti-aging effects 
(O’Sullivan and Karlseder, 2012).
The loss of histones in senescent cells is, however, compli-
cated by the fact that total nuclear protein content actually 
increases (De Cecco et al., 2011). Histone loss during senescence 
is accompanied by recruitment of high mobility group (HMG) 
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It would also be of great interest to know the in vivo occur-
rence of CCFs, examining a variety of tissues, ages, or patho-
logical states.
It is currently unclear whether the low frequency of CCFs 
may be explained by a dynamic steady state, where cells con-
tinuously produce and turn over CCFs (like a conveyor belt), or 
if CCF formation occurs only in a distinct subpopulation of se-
nescent cells. However, given that CCFs appear to contain DNA 
as well as histones, neither alternative readily explains the rela-
tive stability of nuclear DNA levels in the face of significantly 
declining levels of core histones. It may be that histones can 
also be depleted by a CCF-independent process. Further charac-
terization of the CCFs, their content, and turnover should shed 
light on these issues.
Notwithstanding these uncertainties, the work of Ivanov 
et al. (2013) presents a picture of very substantial loss of nuclear 
composition and integrity, especially if extrapolated over long 
periods of time. It is hard to reconcile these degenerative 
changes with the many historical observations of the apparent 
long-term stability and viability of senescent cells. Recent 
studies have suggested that senescent cells can be manipulated 
to regain proliferative capacity by modulating the interaction 
with the extracellular matrix (Choi et al., 2011), or by repro-
gramming using induced pluripotent stem cell (iPSC) technol-
ogies (Lapasset et al., 2011). At face value, one would surely 
expect the processes described by Ivanov et al. (2013) to have 
profoundly negative effects on cell survival, and make cell 
cycle reentry unlikely for cells that have entered deeper stages 
of senescence.
It will also be important to develop a coherent nomencla-
ture for describing the apparently dynamic state of cellular senes-
cence. The classical criterion of irreversible proliferation arrest 
thus likely represents only an early, or “shallow” step in the pro-
cess. These shallow steps may not even be necessary, given a re-
cent report that differentiated, postmitotic cells can acquire some 
features of senescence (Jurk et al., 2012). It has been speculated 
that “senescent after differentiation” (SAD) cells may signifi-
cantly affect the development of a variety of age-related diseases 
in humans (Naylor et al., 2013).
In a more mechanistic vein, it will be critically important 
to define the molecular and cellular markers of a deeply senes-
cent cell versus an early senescent cell. Furthermore, it will be 
necessary to determine the chronology, and most importantly 
functional relevance, of these steps during the “deepening” pro-
cess. Such knowledge would address the possibility of turning 
back cells, at specific points during the progression of senes-
cence, into potentially normally functioning cells. It will also be 
relevant to compare these features in vitro and in vivo. For 
example, if “deepening” is observed in vivo, do the markers of 
this process vary between tissues and organisms? Do they vary 
between oncogene-induced senescence and other forms? There 
are obviously many, many interesting questions to investigate, 
but Ivanov et al. (2013) have provided us with an intriguing first 
look into where these paths may take us.
Submitted: 30 May 2013
Accepted: 6 June 2013
proteins to heterochromatic foci (Funayama et al., 2006; Narita 
et al., 2006). It is therefore likely that the chromatin of senescent 
cells undergoes a transition from being packed with histones to 
nonhistone proteins. It will be interesting to determine the iden-
tity of these nonhistone proteins in future studies.
One perplexing observation made by Ivanov et al. (2013) 
is that relatively few cells exhibit CCFs, even in fully senes-
cent cultures. Furthermore, the number of CCFs formed is also 
quite low, usually less than two foci per cell. Hence, CCF for-
mation alone would not appear to represent a robust biomarker 
for defining deeply senescent cells. The lysosomal processing 
of CCFs raises the interesting issue of whether these processes 
in any way reinforce other known senescence phenotypes. 
For example, one could ask whether the proteolytically cleaved 
products can serve as input material to promote the senescence-
associated secretory phenotype (SASP; Coppé et al., 2008). 
Figure 1. A schematic representation of the processes that lead to the 
establishment of cellular senescence. The progression of senescence has 
been separated into several components: (1) triggering events; (2) initia-
tion of the senescence response; (3) entry into senescence; and (4) a further 
deepening of senescence phenotypes. Stages 2 and 3 can be separated 
by a period of attempted repair, which may result in recovery and survival 
in a healthy postmitotic state, or even resumption of cell proliferation. Entry 
into senescence is likely the result of the acquisition of irreparable damage, 
followed by an extended period during which additional degenerative 
changes can take place, evolve, and accumulate. On the right are illus-
trated some of the many molecular phenotypes, or biomarkers, that have 
been associated with cellular senescence. This listing is not meant to be 
comprehensive and similarly, the order is not meant to imply the chrono-
logical acquisition of these features. The construction of such a timeline 
we believe constitutes an important challenge for the field going forward. 
DDR, DNA damage response.
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and reactive oxygen production is necessary for cell senescence. Mol. 
Syst. Biol. 6:347. http://dx.doi.org/10.1038/msb.2010.5
Wang, J., G.J. Geesman, S.L. Hostikka, M. Atallah, B. Blackwell, E. Lee, P.J. 
Cook, B. Pasaniuc, G. Shariat, E. Halperin, et al. 2011. Inhibition of acti-
vated pericentromeric SINE/Alu repeat transcription in senescent human 
adult stem cells reinstates self-renewal. Cell Cycle. 10:3016–3030. http://
dx.doi.org/10.4161/cc.10.17.17543
References
Campisi, J., and F. d’Adda di Fagagna. 2007. Cellular senescence: when bad 
things happen to good cells. Nat. Rev. Mol. Cell Biol. 8:729–740. http://
dx.doi.org/10.1038/nrm2233
Chen, J.H., and S.E. Ozanne. 2006. Deep senescent human fibroblasts show di-
minished DNA damage foci but retain checkpoint capacity to oxidative 
stress. FEBS Lett. 580:6669–6673. http://dx.doi.org/10.1016/j.febslet 
.2006.11.023
Choi, H.R., K.A. Cho, H.T. Kang, J.B. Lee, M. Kaeberlein, Y. Suh, I.K. Chung, 
and S.C. Park. 2011. Restoration of senescent human diploid fibroblasts 
by modulation of the extracellular matrix. Aging Cell. 10:148–157. http://
dx.doi.org/10.1111/j.1474-9726.2010.00654.x
Collado, M., M.A. Blasco, and M. Serrano. 2007. Cellular senescence in cancer 
and aging. Cell. 130:223–233. http://dx.doi.org/10.1016/j.cell.2007.07 
.003
Coppé, J.P., C.K. Patil, F. Rodier, Y. Sun, D.P. Muñoz, J. Goldstein, P.S. Nelson, 
P.Y. Desprez, and J. Campisi. 2008. Senescence-associated secretory 
phenotypes reveal cell-nonautonomous functions of oncogenic RAS and 
the p53 tumor suppressor. PLoS Biol. 6:2853–2868. http://dx.doi 
.org/10.1371/journal.pbio.0060301
De Cecco, M., J. Jeyapalan, X. Zhao, M. Tamamori-Adachi, and J.M. Sedivy. 
2011. Nuclear protein accumulation in cellular senescence and organis-
mal aging revealed with a novel single-cell resolution fluorescence 
microscopy assay. Aging (Albany NY). 3:955–967.
De Cecco, M., S.W. Criscione, E.J. Peckham, S. Hillenmeyer, E.A. Hamm, 
J. Manivannan, A.L. Peterson, J.A. Kreiling, N. Neretti, and J.M. 
Sedivy. 2013. Genomes of replicatively senescent cells undergo global 
epigenetic changes leading to gene silencing and activation of transpos-
able elements. Aging Cell. 12:247–256. http://dx.doi.org/10.1111/acel 
.12047
Feser, J., D. Truong, C. Das, J.J. Carson, J. Kieft, T. Harkness, and J.K. Tyler. 
2010. Elevated histone expression promotes life span extension. Mol. 
Cell. 39:724–735. http://dx.doi.org/10.1016/j.molcel.2010.08.015
Funayama, R., M. Saito, H. Tanobe, and F. Ishikawa. 2006. Loss of linker his-
tone H1 in cellular senescence. J. Cell Biol. 175:869–880. http://dx.doi 
.org/10.1083/jcb.200604005
Hayflick, L., and P.S. Moorhead. 1961. The serial cultivation of human diploid cell 
strains. Exp. Cell Res. 25:585–621. http://dx.doi.org/10.1016/0014-4827 
(61)90192-6
Ivanov, A., J. Pawlikowski, I. Manoharan, J. van Tuyn, D. Nelson, T.S. Rai, 
P. Shah, G. Hewitt, V. Korolchuk, J.F. Passos, et al. 2013. Lysosome- 
mediated processing of chromatin in senescent cells. J. Cell Biol. 
202:129–143.
Jurk, D., C. Wang, S. Miwa, M. Maddick, V. Korolchuk, A. Tsolou, E.S. Gonos, 
C. Thrasivoulou, M.J. Saffrey, K. Cameron, and T. von Zglinicki. 2012. 
Postmitotic neurons develop a p21-dependent senescence-like phenotype 
driven by a DNA damage response. Aging Cell. 11:996–1004. http://
dx.doi.org/10.1111/j.1474-9726.2012.00870.x
Kuilman, T., C. Michaloglou, W.J. Mooi, and D.S. Peeper. 2010. The essence 
of senescence. Genes Dev. 24:2463–2479. http://dx.doi.org/10.1101/ 
gad.1971610
Lapasset, L., O. Milhavet, A. Prieur, E. Besnard, A. Babled, N. Ait-Hamou, J. 
Leschik, F. Pellestor, J.M. Ramirez, J. De Vos, et al. 2011. Rejuvenating 
senescent and centenarian human cells by reprogramming through the 
pluripotent state. Genes Dev. 25:2248–2253. http://dx.doi.org/10.1101/ 
gad.173922.111
Narita, M., M. Narita, V. Krizhanovsky, S. Nuñez, A. Chicas, S.A. Hearn, M.P. 
Myers, and S.W. Lowe. 2006. A novel role for high-mobility group a 
proteins in cellular senescence and heterochromatin formation. Cell. 
126:503–514. http://dx.doi.org/10.1016/j.cell.2006.05.052
Naylor, R.M., D.J. Baker, and J.M. van Deursen. 2013. Senescent cells: a novel 
therapeutic target for aging and age-related diseases. Clin. Pharmacol. 
Ther. 93:105–116. http://dx.doi.org/10.1038/clpt.2012.193
Ni, Z., A. Ebata, E. Alipanahiramandi, and S.S. Lee. 2012. Two SET domain 
containing genes link epigenetic changes and aging in Caenorhabditis 
elegans. Aging Cell. 11:315–325. http://dx.doi.org/10.1111/j.1474-9726 
.2011.00785.x
O’Sullivan, R.J., and J. Karlseder. 2012. The great unravelling: chromatin as a 
modulator of the aging process. Trends Biochem. Sci. 37:466–476. http://
dx.doi.org/10.1016/j.tibs.2012.08.001
O’Sullivan, R.J., S. Kubicek, S.L. Schreiber, and J. Karlseder. 2010. Reduced 
histone biosynthesis and chromatin changes arising from a damage signal 
at telomeres. Nat. Struct. Mol. Biol. 17:1218–1225. http://dx.doi.org/10 
.1038/nsmb.1897
Passos, J.F., G. Nelson, C. Wang, T. Richter, C. Simillion, C.J. Proctor, S. Miwa, 
S. Olijslagers, J. Hallinan, A. Wipat, et al. 2010. Feedback between p21 
 o
n
 Septem
ber 18, 2013
jcb.rupress.org
D
ow
nloaded from
 
Published July 1, 2013
